A phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia
一项针对核心结合因子急性髓系白血病患者的强化化疗联合或不联合达沙替尼的3期研究
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2025030722
Döhner, Hartmut; Späth, Daniela; Saadati, Maral; Fiedler, Walter; Götze, Katharina; Koller, Elisabeth; Westermann, Jörg; Vogel, Wichard; Heuser, Michael; Lübbert, Michael; Tischler, Hans-Joachim; Germing, Ulrich; Teichmann, Lino L; Fransecky, Lars; Wölfler, Albert; Nachbaur, David; Hertenstein, Bernd; Schroers, Roland; Martens, Uwe; von Harsdorf, Stephanie; Radsak, Markus; Aschauer, Gregor; Weißhaar, Stefanie; Corbacioglu, Andrea; Schrade, Anika; Gaidzik, Verena I; Thol, Felicitas; Paschka, Peter; Bullinger, Lars; Benner, Axel; Döhner, Konstanze; Ganser, Arnold
